A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in...

Autor: Camilleri, Michael, Chey, William Y., Mayer, Emeran A., Northcutt, Allison R., Heath, Amy, Dukes, George E., McSorley, David, Mangel, Allen M.
Předmět:
Zdroj: Archives of Internal Medicine; 7/23/2001, Vol. 161 Issue 14, p1733, 8p, 1 Diagram, 2 Charts, 4 Graphs
Abstrakt: Discusses results of a study evaluating the role of serotonin type 3 receptor antagonist in women with diarrhea-predominant irritable bowel syndrome (IBS). Patient characteristics; Percent who experienced relief after alosetron treatment in diarrhea-predominant IBS versus placebo; Effect of alosetron on stool quality; Common side effect of alosetron use.
Databáze: Complementary Index